TY  - GEN
AU  - Fox,C P
AU  - Burns,D
AU  - Parker,A N
AU  - Peggs,K S
AU  - Harvey,C M
AU  - Natarajan,S
AU  - Marks,D I
AU  - Jackson,B
AU  - Chakupurakal,G
AU  - Dennis,M
AU  - Lim,Z
AU  - Cook,G
AU  - Carpenter,B
AU  - Pettitt,A R
AU  - Mathew,S
AU  - Connelly-Smith,L
AU  - Yin,J A L
AU  - Viskaduraki,M
AU  - Chakraverty,R
AU  - Orchard,K
AU  - Shaw,B E
AU  - Byrne,J L
AU  - Brookes,C
AU  - Craddock,C F
AU  - Chaganti,S
TI  - EBV-associated post-transplant lymphoproliferative disorder following in vivo T-cell-depleted allogeneic transplantation: clinical features, viral load correlates and prognostic factors in the rituximab era
SN  - 1476-5365
PY  - 2014///1103
KW  - Adult
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Cohort Studies
KW  - Epstein-Barr Virus Infections
KW  - drug therapy
KW  - Female
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Immunotherapy
KW  - Lymphoproliferative Disorders
KW  - virology
KW  - Male
KW  - Middle Aged
KW  - Prognosis
KW  - Retrospective Studies
KW  - Rituximab
KW  - Survival Analysis
KW  - Transplantation Conditioning
KW  - Viral Load
N1  - Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bmt.2013.170
ER  -